January Therapeutics: Starting the New Year with Strategic Compounding for Common Post-Holiday Cases

The start of a new year in veterinary practice brings a unique case load. After the holidays, we often see the consequences of disrupted routines, dietary indiscretions, and delayed care. This January presents an opportunity to reset not only for our clients and their pets but also for our approach to treatment. A proactive, strategic use of compounded medications can set the tone for a successful year of patient care. Let’s explore how specific, perhaps underutilized, compounded formulations can efficiently address the most common post-holiday presentations and help you turn seasonal challenges into clinical successes.

Medication 1: Fenbendazole + Metronidazole Oral Suspension – The Post-Holiday GI Reset

The January Scenario: The post-holiday period often sees an influx of pets with chronic, intermittent, or unresolved gastrointestinal issues. Rich foods, stress, and travel can exacerbate underlying conditions like Inflammatory Bowel Disease (IBD) or create a perfect storm for parasitic flare-ups and bacterial imbalances.

Why This Combination is a January Powerhouse:
This dual-action suspension is designed for cases where the exact cause of GI distress is multifactorial or unclear—a common January presentation.

• Fenbendazole: Addresses potential parasitic contributors (like Giardia), which can be picked up in boarding or from new environments during holiday travel.

• Metronidazole: Targets bacterial overgrowth and provides anti-inflammatory effects on the gut lining.

Strategic Advantage for the New Year:
Instead of sequentially testing and treating for parasites versus bacteria—a process that extends patient discomfort and client cost—this formulation allows you to address both common post-holiday GI antagonists simultaneously. It’s a decisive, efficient way to resolve vague diarrhea and vomiting cases quickly, getting pets (and their owners) back on track.

Medication 2: Metronidazole Benzoate + Enrofloxacin + Prednisone Oral Suspension – For the Severe Inflammatory Crisis

The January Scenario: Some post-holiday cases are more severe: the acute hemorrhagic gastroenteritis, the explosive IBD flare, or the pancreatitis case with suspected secondary infection. These patients need aggressive, multi-modal intervention to stabilize.

Why This Triple-Formulation is a Critical Tool:
This compounded suspension is essentially an advanced therapeutic cocktail for severe GI inflammation and dysbiosis.

• Metronidazole Benzoate: A gentler, more palatable form of metronidazole for GI antibiotic/anti-inflammatory action.

• Enrofloxacin: A potent broad-spectrum antibiotic to address or prevent secondary bacterial translocation from a compromised gut.

• Prednisone: A powerful steroid to rapidly quell severe inflammation.

January Application:
Having access to this compounded combination means you can send a critically ill patient home with a single, comprehensive treatment instead of three separate medications. This dramatically increases the likelihood of owner compliance during a stressful time and can prevent hospitalization, easing the burden on your clinic during a busy period.

Medication 3: Ketoconazole 100mg Quadrisect Tablet (Chicken Flavor) – Addressing Resistant Skin & Systemic Issues

The January Scenario: Stress and diet changes can trigger flare-ups of chronic skin conditions like severe yeast dermatitis or Malassezia overgrowth. Additionally, the new year is when many practices reassess management plans for endocrine diseases like Cushing's.

The Formulation's Strategic Edge:
Ketoconazole is a potent antifungal and, at higher doses, an adrenal suppressant. The quadrisect (four-way split) tablet is key.

• Precision Dosing: Allows for exact, incremental dosing adjustments, which is crucial for both dermatology cases and the sensitive management of endocrine conditions.

• Improved Compliance: The chicken flavoring is essential for a medication that often requires long-term administration.

• Cost-Effective for Clients: The ability to split one higher-strength tablet is often more economical than prescribing multiple lower-strength pills.

New Year Protocol Integration:
Make this medication part of your January "chronic case review." For the dog with perennial skin issues or the Cushing's patient needing adjustment, discuss with the owner whether a more palatable, precisely dosed form could improve their pet's quality of life and treatment consistency for the year ahead.

Conclusion: Set a New Standard of Care This January
The beginning of the year is the perfect time to integrate new solutions into your practice. By having these specific compounded formulations in your treatment arsenal, you’re equipped to handle the post-holiday case load with greater efficiency, precision, and success. You’re not just treating symptoms; you’re providing strategic, comprehensive care that can define a pet’s health trajectory for the entire year.

Your January Action Plan:

1. Audit your pharmacy: Do you have these formulations ready, or do you know you can get them from PetScript within 1-2 business days?

2. Train your team: Ensure technicians know about these options for common post-holiday presentations.

3. Start the conversation: With clients of chronic patients, ask: “How did the holidays go with Fluffy’s medication? Would a different form make this year easier?”

4. Order strategically: Use your PetScript account to ensure you have the medications needed to start the year strong and responsive.